Genital Diseases, Male  >>  goserelin acetate  >>  Phase 3
Welcome,         Profile    Billing    Logout  

11 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
NCT00841113: Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer

Completed
3
177
Europe
Abarelix, Plenaxis, Goserelin plus Bicalutamide
Speciality European Pharma Limited
Prostate Cancer
02/01
02/03
NCT01394263: Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Completed
3
59
NA
Histrelin hydrogel implant, Vantas, Zoladex goserelin implant, Zoladex
Endo Pharmaceuticals
Prostate Cancer, Adenocarcinoma of the Prostate
12/01
12/03
NCT00831233 / 2008-004338-26: Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Terminated
3
42
Europe
Degarelix, FE200486, Goserelin, Zoladex, Bicalutamide, Casodex
Ferring Pharmaceuticals
Prostate Cancer
06/10
07/10
NCT00946920 / 2008-005276-27: A Trial of Degarelix in Patients With Prostate Cancer

Completed
3
859
US, Canada, Europe, RoW
Degarelix, Firmagon, FE200486, Goserelin acetate, Zoladex
Ferring Pharmaceuticals
Prostate Cancer
03/11
03/11
NCT00884273 / 2008-008604-40: Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients

Completed
3
182
Europe, RoW
Degarelix, FE200486, FIRMAGON, Goserelin, ZOLADEX, Bicalutamide, CASODEX
Ferring Pharmaceuticals
Prostate Cancer
03/11
03/11
NCT00833248 / 2008-005232-33: Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Completed
3
246
US, Europe
Degarelix, FE200486, Firmagon, Goserelin, Zoladex, Bicalutamide, Casodex
Ferring Pharmaceuticals
Prostate Cancer
09/11
09/11
NCT01242748 / 2010-021434-55: A Degarelix Trial in Patients With Prostate Cancer

Terminated
3
288
US, Canada, Europe, RoW
Degarelix, Firmagon, FE200486, Goserelin acetate, Zoladex
Ferring Pharmaceuticals
Prostate Cancer
12/11
01/12
NCT00423475: Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer

Completed
3
743
Europe
goserelin acetate, ZOLADEX, adjuvant therapy, radiation therapy
UNICANCER, AstraZeneca
Prostate Cancer
03/15
 
NCT01744366: One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population

Completed
3
285
RoW
Degarelix, Goserelin
Ferring Pharmaceuticals
Prostate Cancer
05/15
05/15
ELAAT, NCT00439751: Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy

Completed
3
79
Canada
Goserelin Acetate, Zoladex®, Zoladex® LA
Ontario Clinical Oncology Group (OCOG), AstraZeneca
Prostate Cancer
12/15
06/16
NCT02015871: An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer

Completed
3
206
RoW
Degarelix
Ferring Pharmaceuticals
Prostate Cancer
08/17
08/17

Download Options